Key result
Anesthesia management for totally thoracoscopic cardiac surgery was associated with 0% 30-day mortality, 18.4% intraoperative hypoxemia, and 12.6% pneumonia.
Why the study?
Anesthesia management of totally thoracoscopic cardiac surgery has been the subject of ongoing debate and discussion.
Does the described anesthesia management for totally thoracoscopic cardiac surgery result in acceptable morbidity and length of stay in patients undergoing valve surgery?
Observational (n=103)
No
Does the described anesthesia management for totally thoracoscopic cardiac surgery result in acceptable morbidity and length of stay in patients undergoing valve surgery?
Anesthesia management for totally thoracoscopic cardiac surgery is associated with acceptable morbidity and no 30-day mortality, providing a feasible approach for these procedures.
Supports feasibility of this anesthesia approach in thoracoscopic valve surgery; leaves open need for randomized confirmation of safety.
Anesthesia management of Totally thoracoscopic cardiac surgery (TTCS) has been the subject of much debate and discussion. In this single center retrospective study, we summarize the experience of clinical anesthesia management for TTCS by review the medical records of our medical center and look forward to its future development. In this retrospective study, 103 patients (49 male and 54 female) were enrolled, the mean age was 56.7 ± 14.4 years old. The participants underwent Mitral Valve Replacement (MVR) + Tricuspid Valve Annuloplasty (TVA) (42, 40.8%), Mitral Valve Annuloplasty (MVA) + TVA (38, 36.9%), MVA (21, 20.4%), and MVR (2, 1.9%)，respectively. Intraoperative hypoxemia, radiographic pulmonary infiltrates, and pneumonia were observed in 19 (18.4%), 84 (81.6%), and 13 (12.6%) patients, respectively. The LOS of ICU and POD were as follows: MVR + TVA (55.1 ± 25h, 9.9 ± 3.5 d), MVA + TVA (56.5 ± 28.4h, 9.4 ± 4.2d), MVA (37.9 ± 21.9h, 8.1 ± 2.3d) and MVR (48 ± 4.2h, 7.5 ± 2.1d). No reintubation, reoperations, postoperative cognitive dysfunction, 30-day mortality were observed in the present study. The present study demonstrated that applying this anesthesia management for TTCS associated with acceptable morbidity, intensive care unit and postoperative hospital lengths of stay. The finding from the present study might provide some new approach for Anesthesia management of TTCS.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2023) conducted an observational in Totally thoracoscopic cardiac surgery (n=103). Anesthesia management for totally thoracoscopic cardiac surgery was evaluated. Anesthesia management for totally thoracoscopic cardiac surgery was associated with 0% 30-day mortality, 18.4% intraoperative hypoxemia, and 12.6% pneumonia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: